Advancing ADHD Management: Best Practices and Innovations for Optimal Care—October 23, 2025
Educational Objectives:
At the conclusion of the lecture, the participants should be better able to:
- Differentiate between ADHD subtypes and integrate the latest diagnostic criteria into clinical practice.
- Identify pharmacologic and non-pharmacologic treatment strategies for managing ADHD across different age groups.
- Create individualized treatment plans for patients with ADHD, taking into account comorbidities and patient preferences.
Target Audience:
Multiple Specialties
Accreditation/Credit Designation:
Texas Children’s Hospital is accredited by the Texas Medical Association to provide continuing medical education for physicians. Texas Children’s Hospital designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure:
Texas Children's Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible company (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.
The following faculty has reported no/ the following relevant financial relationships with any ineligible company related to the content of this activity:
| Name of individual | Individual's role in activity | Nature of Relationship(s) / Name of Ineligible Company(s) |
| Janki Patel | Faculty | Nothing to disclose - 08/08/2025 |
| Shamera Beckham, Other | Activity Coordinator | Nothing to disclose - 03/26/2025 |
| Giancarlo Toledanes, DO | Course Director | Nothing to disclose - 01/09/2025 |
| Audrey P Voss | Other Planning Committee Member | Nothing to disclose - 01/13/2025 |
| Orlando Julian, MD | Other Planning Committee Member | Nothing to disclose - 01/09/2025 |
Statement of Ineligible Company Support:
No commercial support has influenced the planning, implementation, or evaluation of the content of this activity.
Contact Information:
Contact Name: Shamera Beckham, MBA
Email: slbeckha@texaschildrens.org